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Paracrine interaction drives EMT and lethal progression of prostate 
cancer: from biology to therapy 
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Prostate cancer progression toward the development of lethal bone and soft tissue 
metastases are major cause of morbidity and mortality in patients. Based on the 
characterization of a series of isogenic human prostate cancer cell lines recapitulating the 
lethal progression of human prostate cancer metastases, we found prostate cancer cells 
with bone metastatic potential, expressed bone-like proteins (osteomimicry), including 
osteocalcin, osteopontin, bone sialoprotein, osteonectin, receptor activator of NF-B 
(RANK), RANK ligand (RANKL), and/or osteoprotegerin (OPG).  
2-Microglobulin (2-M), a light chain of MHC class 1 molecule, was identified as a 
host factor from tumor microenvironment, driving Epithelial to Mesenchymal Transition 
(EMT), osteomimicry, lethal bone and soft tissue metastases. A novel 2-M receptor, the 
hereditary hemochromatosis gene HFE (a MHC-like protein), is responsible for the 
regulation of intracellular iron through binding to transferrin and transferrin receptor, and 
regulating the status of oxidative stress of cancer cells. Anti-2-M monoclonal antibody 
(anti-2-M Ab) was found to target effectively EMT and cancer bone colonization in 
mice.  
RANKL, another target gene of 2-M, was shown to participate in osteoclastogenesis 
associated with cancer bone metastases. RANKL expressed by metastatic castration 
resistant prostate cancer (CRPC) cells and tissues participated directly in prostate cancer 
bone metastases. These data are consistent with the clinical results where targeting 
RANKL-RANK axis with bisphosphonates (Zoledronic Acid) or Denosumab (a RANKL 
monoclonal antibody) reduced bone pain and skeletal related events in CRPC patients 
treated with androgen deprivation therapy.   
New approaches targeting osteomimicry and the converging signaling between 
RANKL/RANK and HGF/SF/c-MET will be described from the perspective of 
developing novel therapies for the control of bone and soft tissue metastasis and the 
lethal progression of prostate cancer in patients (supported by NCI PO-1 and RO-1 grants 
and PCF Challenge Award. 
 
Keywords: prostate cancer, control of bone and soft tissue metastasis 
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Aim: The following applied research approaches are used at ICB: 1) development of 
novel efficient bio-targeting carriers for drug and gene (siRNA) delivery; 2) development 
of novel carriers for delivery of water-insoluble drugs; 3) application of novel labeling 
materials for visualization of drug delivery, action, and clearance in the organism; 4) 
development of nano(micro)particles for cell isolation and separation.  
Methods: Novel polymeric nanocomposites (1) and superparamagnetic nanoparticles (2) 
were synthesized at Lviv National Polytechnic University (1), Kyiv National University 
(1), and Institute of Macromolecular Chemistry (IMC, Prague, Czech Republic) (2). 
Those materials were functionalized for providing them bio-targeting characteristics. 
Flow cytometry, light and fluorescent microscopy, Western-blot analysis of expression of 
proapoptotic proteins, in vivo toxicity studies in mice, and chemotherapy treatment of 
tumor-bearing mice were applied at characterization of the developed drug carriers. 
Specific approaches for detection, selection and addressed targeting the apoptotic cells 
have been also developed.  
Results: To address the NanoBioTech research tasks within the RECOOP Association, 
superparamagnetic nanoparticles were synthesized at IMC, functionalized at ICB, and 
used to monitor phagocytic activity of macrophages. Besides, similar particles were bio-
functionalized by specific lectins, and used to isolate different murine lymphoma cells. 
Polymeric nanoparticles were designed and decorated with specific lectins for addressed 
targeting the apoptotic cells. Effective gene delivery to microorganisms and mammalian 
cells was achieved by the developed polymeric nanocomposites. They showed low 
toxicity and no mutagenicity.  
Conclusions: ICB research team is ready to discuss common design of novel 
nanocomposites, their bio-functionalization, and application for achieving different joint 
research tasks within collaborative biomedical projects of the RECOOP Association.  
Keywords: nanocarriers, drug delivery, gene delivery, treatment, diagnostics, apoptosis. 
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Aim: Introducing to medicine and biology concept of optical markers in tremendous way 
has changed the recent status of these two important disciplines. This was mainly due to 
strong development in imaging techniques which recently allow us to investigate both 
static as well dynamic properties of living cells, their components and their interactions 
with external factors.    
Method and results: Recently used molecular markers including organic dyes, 
fluorescent proteins or chelates containing lanthanide ions have several significant 
limitations. One of the alternatives for molecular markers are inorganic quantum dots (ie. 
CdSe, CdS) which are commonly used in many academic works. However, even if they 
are much better from physico-chemical point of view, from the application point of view 
at this moment they are rather useless mainly because of their high risk of toxicity. One 
of the solution combining advantages of both concepts is to make nontoxic inorganic 
nanocrystals doped by lanthanide ions.  
Conclusion: In this work, we will present optical results obtained for NaYF4, NaGdF4 
and GdOF nanocrystals doped by different lanthanide ions (Eu, Tb, Nd). The aim of this 
work was to design and to synthesize these markers and to understand physical processes 
responsible for their emission/excitation and to optimize these processes to the physical 
limits. 
Keywords: nanocrystal, rare earth ions, GdOF 
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Aim: It is important in regenerative medicine to noninvasively track stem cells to 
evaluate their therapeutic effect and grafting location to rule out side effects. Magnetic 
nanoparticles are therefore being developed as labels visualized by MRI in in vivo cell 
tracking. Before evaluating the clinical potential of nanoparticles in cell transplantation, 
the effect of these particles on cultured cells should be assessed. As a model, we chose 
human mesenchymal stem cells (hMSCs) as they are widely used in the regeneration of 
connective tissues (bone, cartilage and fat). We studied the basic properties of hMSCs 
labeled with superparamagnetic nanoparticles: labeling efficiency, cell growth, 
proliferation, migration and differentiation. 
Methods: hMSCs were labeled with neat or poly (L-lysine) (PLL)-coated 
superparamagnetic γ-Fe2O3 nanoparticles prepared by an original procedure. Labeling 
efficiency, cell proliferation and migration were determined by counting the number of 
Prussian Blue-stained and unstained cells using a cell analyzer. Cell migration was 
studied using SDF1 factor as a chemoatractant. The osteogenic, chondrogenic and 
adipogenic differentiation potential of nanoparticle-labeled MSCs was also determined. 
Results: The efficiency of cell labeling for PLL-coated and uncoated γ-Fe2O3 was 91.5 % 
and 45 %, respectively. The magnetic label slightly reduced cell proliferation during the 
first 10 h; however, the final PLL-γ-Fe2O3-labeled cell index was high after 24 h. 
Compared to unlabeled cells, cell migration towards the chemoattractant was not 
affected. No difference was found in the gene expression of LPL and PPARG adipogenic 
markers, while osteogenic gene expression (ALPL and RunX2) slightly decreased. 
However, histological examination revealed that osteogenic (Alizarin Red), chondrogenic 
(Alcian Blue) and adipogenic (Red Oil O) differentiation were not affected. 
Conclusions: Even a highly efficient cell label, PLL-γ-Fe2O3, does not significantly 
affect basic stem cell properties and therefore can be considered as a suitable contrast 
agent for in vivo monitoring of transplanted stem cells in different applications, such as 
the transplantation of MSCs into cartilage or bone defects. 
Keywords: magnetic, stem cells, labeling 
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Aim: Metal nanoparticles (NPs), such as gold (Au) and silver (Ag), have recognized 
importance in chemistry, physics, and biology due to their unique optical, electrical, and 
photothermal properties. AuNPs have photothermal properties that can be exploited for 
localized heating which results in drug release, thus increasing their potential for 
therapeutic applications of some malignant diseases (melanoma, hepatocarcinoma).  
The aim of the present study was to immobilize the recombinant human arginase I on 
AuNPs and AgNPs and to characterize the obtained enzyme-NPs: analyses of their size, 
structure, enzymatic activity and stability.  
Methods: The size and structure of the AgNPs and AuNPs were characterized using 
TEM, AFM and XRD analyses. 
Results: The synthesis of silver and gold nanoparticles was carried out by reduction of 
silver nitrate by glucose and reduction of tetrachloroauric acid by sodium citrate, 
respectively. Recombinant arginase I was immobilized using the carbodiimide method on 
the surface of NPs functionalized with ω-mercaptohexadecanoic acid. Recombinant 
human arginase I was successfully linked on both NPs with a binding efficiency of 85% 
for AgNPs and 87% for AuNPs (in the range of added enzyme concentration 0.15-0.5 
mg/mL). The nanocomposite-bound arginase was used to construct potentiometric and 
amperometric biosensors for monitoring of arginine level during arginase-based 
enzymotherapy of some cancers.  
Conclusions: Thus, the synthesized gold and silver nano-carriers have a stabilizing effect 
on recombinant human arginase I due to its fixation on the surface of the NPs, preventing 
enzyme inactivation. So, the immobilization procedures open extensive possibilities for 
the construction of very sensitive and stable biosensors for wide biochemical 
applications. A high thermostability of immobilized on NPs arginase I preparations and a 
wide working pH range of this enzyme is predicted to be a perspective tool for 
bioanalytical purposes, namely, for arginine monitoring in pharmaceuticals, in food 
products and in blood. 
Keywords: silver and gold nanoparticles, covalent enzyme immobilization.  
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Aim: To test the hypothesis that activation of c-MET-mediated signaling in prostate 
cancer cells supports cancer cell growth and survival and promotes progression and 
metastasis. We focused on the simultaneous detection and quantification of 5 proteins in 
the c-MET activation pathway, receptor activator of NF-κB ligand (RANKL), VEGF, 
NRPLN-1, p-c-MET and p-p65 (NF-κB) and epithelial to mesenchymal transition (EMT) 
known to be associated with human prostate cancer progression and bone metastasis.  
Methods: We established a novel technology of multiplexed quantum dot labeling, 
MQDL, to detect the expression and activation of multiple c-MET pathway and EMT 
mediators in tissue specimens and subject to signal intensity quantification. Three 
experimental systems were used: 1) human prostate cancer cell model exhibiting 
activated c-Met signaling and bone metastasis; 2) xenograft tissues from an established 
LTL313 castration-resistant human prostate cancer (CRPC) model; and 3) clinical 
prostate cancer tissue specimens. Nuance software was used for image capturing, 
unmixing and inForm software for per cell base intensity quantification of the five 
prostate cancer progression associated proteins in the c-MET activation pathway, 
RANKL, VEGF, NRPLN-1, p-c-MET and p-p65 (NF-κB) and EMT biomarkers 
EpCAM, N-cadherin and RANKL.  
Results: Cell based MQDL quantification data showed that the c-MET activation 
mediators, RANKL, VEGF, NRPLN-1, p-c-MET and p-p65 (NF-κB) and mesenchymal 
biomarkers, N-cadherin and RANKL were all elevated in CRPC human prostate mouse 
xenograft model and in the invasive human prostate cancer with statistical significance. 
Results were confirmed by real-time RT-PCR and western blots in a metastatic human 
prostate cancer cell model.  
Conclusions: Our results showed that activation of c-MET-mediated signaling occurs in 
prostate cancer cells through increased phosphorylated c-MET in all three tested systems. 
The downstream survival signaling network was mediated by NF-κB and EMT driven by 
RANKL, in clinical prostate cancer specimens and the xenograft model.  MQDL is a 
powerful tool for assessing biomarker expression and it offers molecular insights into 
cancer progression at both the cell and tissue level with high degree of sensitivity. 
Keywords: multiplexed quantum dot labeling, c-MET mediators, castration-resistant 
prostate cancer, epithelial to mesencymal transition, metastasis 
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High-risk or oncogenic human papillomaviruses (HPV 16, 18, 31, 33, 35, 39, 45, 51, 52, 
56, etc) are causally linked to the development of cervical cancer. The E6 and E7 
oncoproteins of high-risk HPVs are responsible for the transforming activity of the virus. 
The virus genome is usually found in an episomal form in benign and premalignant 
lesions, while it is frequently integrated in the host cell genome in malignant cancers. The 
E6 and E7 oncogenes are always retained and expressed in the transformed cells. 
During cervical carcinogenesis, genetic and epigenetic alterations disrupting the cell 
cycle control are needed to acquire immortal phenotype and to progress further to overt 
malignant and invasive phenotype. The stepwise accumulation of these alterations is 
manifested in the well-defined clinical stages. 
Epigenetic alterations include those heritable (covalent) modifications of DNA and 
histone proteins that do not result in changes of the genomic DNA sequence. In 
vertebrates, CpG methylation of DNA acts in context with post-translationally modified 
histones and other chromatin-remodelling factors to establish the characteristic gene 
expression profile of individual somatic tissues (2). In cancer, the aberrant functions of 
chromatin modifier enzymes result in altered DNA methylation patterns and histone 
modifications and the epigenetic alterations involved in uncontrolled cellular 
proliferation and viral expression during the multistep process of cervical carcinogenesis. 
 
